Institution
Colorado Blood Cancer Institute
Also known as: CBCI
- 173running trials
- 42closed trials
- 563publications (OpenAlex)
Running trials
Not yet recruiting
Recruiting
A Study of BMS-986528 in Participants With Refractory Rheumatoid Arthritis
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Recruiting
A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Recruiting
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
Recruiting
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Recruiting
Active, not recruiting
A Study of JNJ-79635322 in Participants With Relapsed or Refractory Multiple Myeloma
Recruiting
Recruiting
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Recruiting
Recruiting
A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms
Recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Recruiting
Recruiting
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Quizartinib or Placebo Plus Chemotherapy in Newly Diagnosed Patients With FLT3-ITD Negative AML
Recruiting
Active, not recruiting
Recruiting
APVO436 Phase 1b/2 Study in Patients With Newly Diagnosed AML
Recruiting
A Study to Evaluate Preventive Treatments for GPRC5D-related Oral Events
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Cost Communication and Financial Navigation in Cancer Patients (COSTCOM)
Active, not recruiting
Recruiting
Recruiting
Recruiting
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
Active, not recruiting
Active, not recruiting
Sequential Therapy in Multiple Myeloma Guided by MRD Assessments
Recruiting
LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia
Recruiting
Outpatient Administration of Teclistamab or Talquetamab for Multiple Myeloma
Active, not recruiting
Active, not recruiting
Active, not recruiting
Showing 50 of 173.
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Multiple myeloma21 recruiting
- Acute myeloid leukaemia8 recruiting
- Diffuse large B-cell lymphoma8 recruiting
- Follicular lymphoma8 recruiting
- Childhood cancers7 recruiting
- Chronic lymphocytic leukaemia6 recruiting
- Mantle cell lymphoma6 recruiting
- Acute lymphoblastic leukaemia5 recruiting
- Hodgkin lymphoma4 recruiting
- Amyloidosis3 recruiting
- Myeloproliferative neoplasms3 recruiting
- Melanoma2 recruiting
- Myelodysplastic syndromes2 recruiting
- Aplastic anaemia1 recruiting
- Brain metastases1 recruiting
- Burkitt lymphoma1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Rheumatoid arthritis1 recruiting
- Sarcoma1 recruiting
- Systemic sclerosis (scleroderma)1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Recruiting
Terminated
Terminated
Evaluation of IGM-2644 in Adults With Relapsed and/or Refractory Multiple Myeloma
Completed
Terminated
Study of Brexucabtagene Autoleucel in Adults With Rare B-cell Malignancies
Completed
Terminated
A Study of bbT369 in Relapsed and/or Refractory B Cell Non-Hodgkin's Lymphoma (NHL)
Completed
Phase 1/2 Study of ZN-d5 for the Treatment of Relapsed or Refractory Light Chain (AL) Amyloidosis
Terminated
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Completed
Completed
Cancer Care Delivery in Adolescent and Young Adult Patients With Acute Lymphoblastic Leukemia
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Completed
Terminated
Study of ACY-241 Alone and in Combination With Pomalidomide and Dexamethasone in Multiple Myeloma
Completed
Completed
Completed
Completed
Completed
S1216, Phase III ADT+TAK-700 vs. ADT+Bicalutamide for Metastatic Prostate Cancer
Completed
Scleroderma Treatment With Autologous Transplant (STAT) Study
Completed
S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery
Completed
Completed
Completed
Registry name variants (23)
Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.
Colorado Blood Cancer Institute
Denver, Colorado 80218
194 trials
Colorado Blood Cancer Institute (CBCI)
Denver, Colorado 80218
2 trials
NCT06561347Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
Contact: Peter Forsberg, MD
Colorado Blood Cancer Institute (Sarah Cannon)
Denver, Colorado 80218
2 trials
Colorado Blood Cancer Institute/SCRI
Denver, Colorado 80218
2 trials
Contact: Clinical Trials Administrator
CBCI, Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
Contact: Trial Registration Coordinator
Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute, Lab
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute
Denver, Colorado 80218
1 trial
NCT06544265SynKIR-310 for Relapsed/Refractory B-NHL
Contact: Cicelia Veloz
Colorado Blood Cancer Institute - PPDS
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute/Presbyterian St. Luke's
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute (Sarah Cannon Research Institute)
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute - SCRI - PPDS
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute (Site 0225)
Denver, Colorado 80218
1 trial
Colorado Blood Cancer Institute (Site 2726)
Denver, Colorado 80218
1 trial
Contact: Study Coordinator
Colorado Blood Cancer Institute (Site 7000)
Denver, Colorado 80218
1 trial
NCT07519772A Clinical Study of MK-1045 in People With Non-Hodgkin Lymphoma (MK-1045-008)
Contact: Study Coordinator
Colorado Blood Cancer Institute Site Number : 8400007
Denver, Colorado 80218
1 trial
Presbyterian St. Luke's/Colorado Blood Cancer Institute
Denver, Colorado 80218
1 trial
NCT01351545A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Contact: Alireza Eghtedar, MD
Sarah Cannon Cancer Center - (Colorado Blood Cancer Institute)
Denver, Colorado 80218
1 trial
Conditions
Diseases this institution publishes on or runs trials for.
- Multiple myeloma22 works · 59 trials
Institution data: ROR 040pncp85 (CC0-1.0)Updated 15 Nov 2026